Package 71288-108-06

Brand: cytarabine

Generic: cytarabine
NDC Package

Package Facts

Identity

Package NDC 71288-108-06
Digits Only 7128810806
Product NDC 71288-108
Product ID 71288-108_ba035466-3b01-4e2b-abf5-d876619a2674
Description

5 VIAL, SINGLE-DOSE in 1 CARTON (71288-108-06) / 5 mL in 1 VIAL, SINGLE-DOSE (71288-108-05)

Marketing

Marketing Status
Marketed Since 2020-06-26
Brand cytarabine
Generic cytarabine
Sample Package No

Linked Drug Pages (1)

Cytarabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRATHECAL", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "ba035466-3b01-4e2b-abf5-d876619a2674", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["04079A1RDZ"], "rxcui": ["1731355"], "spl_set_id": ["446f6765-5375-6368-4755-4944574f5721"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Meitheal Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 VIAL, SINGLE-DOSE in 1 CARTON (71288-108-06)  / 5 mL in 1 VIAL, SINGLE-DOSE (71288-108-05)", "package_ndc": "71288-108-06", "marketing_start_date": "20200626"}], "brand_name": "Cytarabine", "product_id": "71288-108_ba035466-3b01-4e2b-abf5-d876619a2674", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "71288-108", "generic_name": "Cytarabine", "labeler_name": "Meitheal Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cytarabine", "active_ingredients": [{"name": "CYTARABINE", "strength": "20 mg/mL"}], "application_number": "ANDA206189", "marketing_category": "ANDA", "marketing_start_date": "20200626", "listing_expiration_date": "20261231"}